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ABSTRACT
We present barcoded oligonucleotides ligated on
RNA amplified for multiplexed and parallel in situ
analyses (BOLORAMIS), a reverse transcription-
free method for spatially-resolved, targeted, in situ
RNA identification of single or multiple targets.
BOLORAMIS was demonstrated on a range of cell
types and human cerebral organoids. Singleplex ex-
periments to detect coding and non-coding RNAs in
human iPSCs showed a stem-cell signature pattern.
Specificity of BOLORAMIS was found to be 92% as
illustrated by a clear distinction between human and
mouse housekeeping genes in a co-culture system,
as well as by recapitulation of subcellular localization
of lncRNA MALAT1. Sensitivity of BOLORAMIS was
quantified by comparing with single molecule FISH
experiments and found to be 11%, 12% and 35% for
GAPDH, TFRC and POLR2A, respectively. To demon-
strate BOLORAMIS for multiplexed gene analysis, we
targeted 96 mRNAs within a co-culture of iNGN neu-
rons and HMC3 human microglial cells. We used fluo-
rescence in situ sequencing to detect error-robust 8-
base barcodes associated with each of these genes.
We then used this data to uncover the spatial rela-
tionship among cells and transcripts by performing
single-cell clustering and gene–gene proximity anal-
yses. We anticipate the BOLORAMIS technology for
in situ RNA detection to find applications in basic
and translational research.
INTRODUCTION
Spatial transcriptomics is a rapidly evolving field, with
recent developments in multiplexed in situ technologies
paving the way for spatial imaging of the genome and tran-
scriptome at an unprecedented resolution (1). Spatial pro-
filing of gene expression patterns in cells of a given tissue
can provide intricate molecular maps, thus allowing quan-
tification of transcripts and understanding of cellular func-
tion in a particular environment. We proposed the idea of
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in situ DNA amplification using PCR in 1999 (2) and ad-
vanced this method to a technology called Fluorescent In
Situ Sequencing (FISSEQ) in 2003 that used fluorescent de-
oxynucleotides for sequencing polonies (3,4). FISSEQ en-
ables high-throughput multiplexing along with high reso-
lution imaging of targets, while keeping morphology of the
samples intact, thus preserving the cellular context, as com-
pared with bulk sequencing methods. Although our idea of
performing FISSEQ in cells was intrinsic to its conception,
it was from 2013 onwards that the generation and sequenc-
ing of highly multiplexed and spatially resolved in situ RNA
libraries in cells and tissues was demonstrated (5,6). While
FISSEQ offers de novo transcriptome sequencing and there-
fore is not targeted to specific transcripts, the detection effi-
ciency and sensitivity is low (<0.005%) (7).
Targeted in situ detection of messenger RNA (mRNA)
gives higher efficiency by reducing background (by relieving
crowding of targets and competition for reagents compared
to whole-transcriptome), thereby increasing the signal-to-
noise ratio. This can be achieved by using barcoded pad-
lock probes designed for specific targets, amplifying the cir-
cularized probes and sequencing the barcodes over multiple
rounds. This method provides a means to map the expres-
sion profile of a subset of transcripts and compare it to the
expression levels in surrounding cells in a given tissue.
Padlock probes have been demonstrated for in situ se-
quencing for multiplexed transcriptomics, with single-base
resolution on a small number of transcripts (6). However,
in both this method and FISSEQ, detection efficiency is a
function of the reverse transcription (RT) step, that results
in a DNA–RNA hybrid, after the formation of which the
RNA needs to be digested away to expose the cDNA. Thus,
this RT step is subject to noise resulting from variable prim-
ing efficiency and random priming induced bias (8). Locked
nucleic acid modified primers have been demonstrated to in-
crease RT efficiency with padlock probes, but require care-
ful calibration and can be cost-prohibitive for genome-wide
applications (5,6,9).
Previously described spatial transcriptomic technologies
that do not require reverse transcription include MER-
FISH (10,11), SeqFISH+ (12,13) and STARmap (14). Both
MERFISH and SeqFISH+ require the targets to be at least
around 1kb to produce enough space for encoding probes
to hybridize, limiting the detection of short transcripts.
STARmap devised a smart strategy of direct short-footprint
RNA targeting using SNAIL (specific amplification of nu-
cleic acids via intramolecular ligation) probes, where two
pieces of DNA probes act together to create a circular tem-
plate upon co-hybridization to the same RNA molecule.
The template length required by SNAIL probes is 40–46 nu-
cleotides (nt). Although much shorter than MERFISH and
SeqFISH+, SNAIL probes used by STARmap do not have
the potential to distinguish finer distinctions between tran-
scripts like point mutations or targeting even shorter tran-
scripts like microRNAs (miRNAs).
To overcome these issues related to the RT step and
requirements for long target sequences, we developed
BOLORAMIS (barcoded oligonucleotides ligated on RNA
amplified for multiplexed and parallel in situ analyses), a re-
verse transcription-free direct RNA detection method. In
this study, we have optimized probe design, demonstrated
specificity and sensitivity, as well as multiplexing capabili-
ties of the method on a set of 96 genes. BOLORAMIS is
based on combinatorial molecular indexing combined with
direct RNA-dependent ligation and clonal amplification of
barcoded padlock probes. In this method, after cell fixa-
tion and permeabilization, the probes are added so that
they directly hybridize to RNA molecules – thus eliminat-
ing the need for conversion of the RNA to cDNA by RT.
The probes are then ligated using SplintR Ligase (15) and
subjected to rolling circle amplification (RCA) to produce
amplicons. The amplicons are then crosslinked to the cel-
lular matrix to prevent translocation and the barcodes are
detected by fluorescent in situ hybridization (FISH) or se-
quenced in situ to get a high-resolution imaging readout
of the bases they encode, to thereby reveal probe identity
(Figure 1A). We demonstrate that BOLORAMIS works
on diverse cell and tissue types including human cerebral
organoids. Using our BOLORAMIS method, we were able
to map the spatial patterns of cells and genes by targeting
96 mRNAs within a co-culture of iNGN neurons (16) and
HMC3 human microglial cells (17).
MATERIALS AND METHODS
Cell culture
Regular maintenance and passaging of cells were per-
formed in standard tissue culture plates. HeLa, MCF7,
NIH-3T3 and HMC3 (ATCC, CRL-3304) cells were cul-
tured in DMEM/F12 (with 10% Fetal Bovine Serum (FBS))
changed every 48 h. Uninduced PGP1 iNGN cells were cul-
tured as described earlier (16). Briefly, tissue culture plates
were precoated with Matrigel (Corning, 354277) following
manufacturer’s instructions. Induced pluripotent stem cells
(iPSCs) were maintained in mTeSR1 (Stemcell Technolo-
gies, 05850) changed every 24 h. For passaging, cells were
incubated with TrypLE Express Enzyme (Thermo Fisher
Scientific, 12604013) for 1–5 min in the incubator until cells
started to detach. 1.5× volume of culture media were added
to terminate the digestion. After gentle aspiration, the en-
tire volume was collected and centrifuged at 300 g for 5
min. Supernatant was removed and cells were resuspended
in culture media. Cells were counted and re-plated to reach
80% confluency after 4 days. iPSCs were re-plated in fresh
mTeSR1 media containing 10 M Y-27632 (ROCK in-
hibitor) (Stemcell Technologies, 72302). For BOLORAMIS
library preparation and imaging, all cell lines used in
this paper were plated on removable chambered coverglass
(Grace Bio-Labs, 112358). For the co-culture of iNGN with
HMC3, monoculture of iNGN iPSCs were induced with
0.5 g/ml doxycycline (Sigma, D3072) after passaging for
4 days. On day 3, monoculture of HMC3 were dissoci-
ated and added to the culture of iNGN for 24 h prior to
fixation.
BOLORAMIS library preparation for non-384 well experi-
ments
Cells were fixed with 4% paraformaldehyde (Electron Mi-
croscopy Sciences) for 15 min, rinsed with phosphate-
buffered saline (PBS) (Life Technologies) and permeabi-
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Figure 1. BOLORAMIS workflow and probe optimization. (A) Schematic of BOLORAMIS workflow. Colors in barcoded probes: blue – hybridization
arm, red – barcodes, black – RCA priming region. Example images of BOLORAMIS library preparation on (B) HeLa (scale bar: 50 m), HEK293, MCF7,
NIH-3T3 cells and (C) human cerebral organoids (scale bar: left 500 m, right 100 m). (D) Representative image of ACTB probe with 18 nt 5′ arm and
7 nt 3′ arm; and its ligation junction single mismatch control (scale bar: 50 m). (E) Mean spot per cell and (F) true discovery rate (TDR, see Materials
and Methods) for ACTB in HeLa cells with the 5′ hybridization arm from 2 nt to 22 nt. Orange dots are 18 nt.
for 15 min. Padlock probes (1 M final probe concentra-
tion for singleplex experiments, 10 M for multiplexed ex-
periments) along with RCA primer (1:1 mole ratio) in Hy-
bridization Buffer (10% formamide in 6× Saline Sodium
Citrate (SSC) buffer) were added to the sample and in-
cubated for 1 h at 37◦C, followed by three 5-min washes
with Hybridization Buffer to remove excess unhybridized
primer and probe, followed by a wash with 1× SplintR Lig-
ase buffer. Ligase mix containing 210 nM (1:50) SplintR
Ligase (New England Biolabs) in 1× SplintR Ligase Re-
action Buffer was added to the sample and incubated for
1 h at room temperature followed by three rinses with the
Hybridization Buffer to remove the unligated products and
enzyme. The samples were then incubated with the RCA
Mix (1 U/l NxGen Phi29 DNA polymerase (Lucigen),
250 M dNTPs, 200 g/ml BSA (New England Biolabs),
40 M Amino-Allyl dUTP (Invitrogen)) in 1× Phi29 DNA
Polymerase Buffer for 2 h at 37◦C followed by three 5-
min washes with 2× SSC buffer. Finally, the samples were
stained with 500 nM Cy3 or Cy5 labelled fluorescent probes
in 6× SSC for 30 min, washed with 6× SSC to remove un-
bound fluorescent probes.
Generation of cerebral organoids
Cerebral organoids were differentiated from human iPSCs
(MH0185983) established elsewhere (18) using a previously
described protocol with modifications (19). Approximately
900 000 iPSCs were seeded into a 96-well ultra-low attach-
ment plates (Corning) with 150 l of mTeSR1 (Stemcell
Technologies) and 50 M ROCK inhibitor (Santa Cruz
Biotechnology), to obtain embryoid bodies (EBs). The me-
dia was replaced with 200 l of neural induction media on
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days, 100 l of the media in each well was replaced. On
day 9, each organoid was placed on parafilm compression,
and 35 l of Matrigel (Corning, 354234) was used for em-
bedding. About 10 embedded organoids were transferred
into one six-well of an ultra-low attachment plate (Thermo
Fisher Scientific) containing 5 ml of differentiation media
(without vitamin A) with 1% antibiotic-antimycotic (peni-
cillin, streptomycin and amphotericin B). On day 15, media
was changed to differentiation media containing vitamin A
and 1% antibiotic–antimycotic, and plates were placed on
an orbital shaker at 90 rpm in the incubator at 37◦C.
Organoid sectioning
46-day old organoids were fixed overnight at 4◦C on a
shaker followed by 3× 30 min washes with PBS at room
temperature. Subsequently, fixed organoids were embedded
in optimal cutting temperature (OCT) compound followed
by rapid freezing on a metal block semi-submerged in liq-
uid nitrogen. The frozen OCT blocks were trimmed and sec-
tioned at 20 m thickness onto Superfrost Plus slides using
the Microm HM505E cryostat.
Library preparation protocol for organoids
Slides containing two 20 m thick organoid sections were
dehydrated with increasing amounts of ethanol from 70 to
100% and left in 100% ethanol for 1 h at room temperature.
Barriers were drawn around sections using a hydropho-
bic pap pen, then sections were permeabilized in Triton X-
100 in PBS for 15 min at room temperature. Sections were
hybridized with probes in hybridization buffer (10% for-
mamide, 6× SSC), with 100 M probes and 200 M RCA
primer for 1 h at 37◦C.
Next, the sections were rinsed once with SplintR Ligase
buffer and then ligated with SplintR Ligase (New England
Biolabs) for 1 h at room temperature. After ligation, sec-
tions were rinsed in Phi29 buffer three times, then incubated
in Phi29 RCA mixture containing Phi29 (Lucigen), Phi29
buffer (Lucigen), 10 mM dNTPs, 2 mM aminoallyl-dUTPs,
20 mg/ml BSA and water at room temperature overnight.
The next day, sections were rinsed in 10 nM MES buffer
(Alfa Aesar) solution and then crosslinked for 1 h at room
temp with 50 mM HEPES buffered saline, and BS(PEG)9.
After 1 h, 20 l 1 M Borate buffer was added to each sec-
tion for 15 additional minutes. Sections were then washed
for 30 min with 1 M Tris and rinsed three times with PBS.
Then FISH probes were added in a solution of hybridiza-
tion buffer at a final concentration of 0.5 M FISH probes
with 1 g/ml DAPI (Invitrogen). Sections were covered
from light and incubated for 30 min at room temperature.
Finally, sections were rinsed three times with hybridization
buffer to wash off probes and then were ready for imaging.
Imaging organoids
Images were taken on a Nikon Ni-E upright fluorescence
microscope using a LED fluorescent light source (Sola
SE2). Images were obtained using a CFI Plan Apo Lambda
10× objective (NA = 0.45) and a CFI Plan Apo VC 60× wa-
ter immersion objective (NA = 1.2). Images were obtained
with a Hamamatsu Flash 4 v3 sCMOS camera using Nikon
Elements imaging software.
Single molecule FISH (smFISH)
smFISH probes for GAPDH (SMF-2026-1), POLR2A
(SMF-2003-1) and TFRC (SMF-2006-1) were acquired
from Stellaris. smFISH was performed according to man-
ufacturer’s instructions (‘Stellaris RNA FISH Protocol for
Adherent Cells’). Cells were cultured on removable cham-
bered coverglass (Grace Bio-Labs, 112358) prior to fixation
of the smFISH samples.
Image acquisition for low-plex BOLORAMIS and smFISH
Images were acquired on a Nikon Ti2 Eclipse inverted mi-
croscope using a Plan Apo Lambda DM 60× (1.4 NA, Ph3)
oil objective and an Andor Zyla sCMOS camera. Images
were acquired using the NIS-Element AR software.
Amplicon and puncta quantification for low-plex
BOLORAMIS and smFISH
For optimization of probe configurations, specificity and
sensitivity test, BOLORAMIS amplicons and smFISH
puncta were quantified in Fiji. Image stacks were com-
bined by maximum intensity projection, followed by back-
ground subtraction, with a rolling ball radius of 10 for
BOLORAMIS and 2 for smFISH. Images were also
smoothed by default settings in Fiji. To quantify the number
of spots in each cell, single cells were manually cropped out
and spots were counted using the 2D/3D particle tracking
function in the Mosaic plugin.
TDR calculation for optimizing probe configuration
A set of 11 probes targeting ACTB mRNA was designed
such that the 5′ hybridization arm length was systemati-
cally varied at two base intervals. The total hybridization
region was kept constant at 25 nt, and the same ligation
junction (dA/A) was maintained for all sets. As a con-
trol, another set of 11 probes targeting ACTB was designed
with only one base mismatch at the 3′ ligation junction
(A>T). Targeted detection was performed as follows: Con-
fluent cultures of HeLa-Cas9 cells (Genecopoeia, SL503)
were treated with 0.05% trypsin–EDTA (Life Technolo-
gies), re-suspended in 1× DMEM (Invitrogen) and seeded
on six channel flowcells (-Slide VI0.4 ibiTreat, Ibidi).
BOLORAMIS library preparation and image quantifica-
tion were performed as described above. True discovery rate
(TDR) is defined as the percentage of total signal observed
from a perfectly matched (M) probe as compared with the
sum signal of a matched and mismatched (MM) probe cal-
culated as (M/(M + MM)) × 100. For example, if a matched
probe results in a mean count of 99 spots/cell, and a mis-
matched probe results in a mean count of 1 spot/cell, then
the TDR is 99%.
Bulk RNA sequencing library preparation
HMC3 cells cultured in six-well plates were treated with
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on the plate. The solution was used for total RNA extrac-
tion using Direct-zol RNA MiniPrep Kit (Zymo Research,
R2050). RNA amount was quantified using Qubit RNA HS
Assay Kit (Thermo Fisher Scientific, Q32852) and RNA in-
tegrity was checked by the presence of 18S and 28S bands
on a 2% E-Gel EX Agarose Gel (Thermo Fisher Scien-
tific, G402002). 1 g RNA was used for library preparation
using NEBNext Ultra II Directional RNA Library Prep
Kit (New England Biolabs, E7760S) following the manu-
facturer’s instructions on combined usage with NEBNext
Poly(A) mRNA Magnetic Isolation Module (New Eng-
land Biolabs, E7490). Library QC and sequencing was per-
formed by the Biopolymers Facility at Harvard Medical
School.
Analysis of RNA sequencing data
A human genome reference index was built by
STAR 2.5.2b using genome primary assembly (ftp:
//ftp.ebi.ac.uk/pub/databases/gencode/Gencode human/
release 27/GRCh38.primary assembly.genome.fa.gz)
and annotation file (ftp://ftp.ebi.ac.uk/pub/databases/
gencode/Gencode human/release 27/gencode.v27.
primary assembly.annotation.gtf.gz) from GENCODE.
Read alignment and quantification were performed using
STAR -quantMode GeneCounts. Raw RNA-seq data for
day 4 iNGN were acquired from GEO (https://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE60548). HMC3
and iNGN gene expression counts were normalized by the
total aligned reads number per sample. Differential gene
expression analysis was performed using DESeq2 (20).
BOLORAMIS probe design
All mRNA-targeting probes were 60 nucleotides (nt), with
a 25-nt RNA targeting region and a 35-nt barcoded linker.
The barcoded linker sequence consisted of a universal 23-nt
sequencing anchor, flanked by two 6-base filler sequences
(Supplementary Table S1). For the 96-plex experiment, the
two 6-base filler sequences were modified to be an 8-base
barcode downstream of the sequencing adapter and a 4-
base barcode upstream that is identical to the last 4 nt of the
8-base barcode. Because nonamer sequencing was shown to
be more reliable within 4 bases (21) from either direction,
the 4-base barcode on one side was copied from the 5–8 po-
sition of the 8-base barcode on the other side. This design
would allow future attempts of sequencing using SOLiD or
Illumina SBS chemistry, which only goes from 5′ to 3′ di-
rection. The sequencing anchor was used for FISH and in
situ sequencing. Phosphorylated probes were ordered from
IDT in 10 nanomoles scale, at a stock concentration of 100
M in plate format, allowing rapid design-build-test cycles.
To design specific and efficient probes for the 96-
plex experiment, factors considered included off-target se-
quence in the transcriptome, ligation junction compati-
bility with SplintR (22) and probe secondary structure.
Target isoforms were manually picked to be the dom-
inant isoform according to Ensembl Genome Browser
and broken up into all possible 25-mers, avoiding ho-
motetrapolymers of guanine. Updated code available at
https://github.com/pawlowac/BoloramisProbeDesign now
avoids homotetrapolymers of cytosine as well. A refer-
ence database was created from the Human Gencode (23)
GRCh38 release 29 by removing any genes with baseMean
< 10 using DESeq2 (20) found during the RNA-seq ex-
periment described above, leaving 15 596 out of 56 653
genes to search for potential off target hybridization of
BOLORAMIS probes. Off-target hybridization was eval-
uated with Bowtie2 (24) v1.2.3 with the following flags; -
D 20 -R 3 -N 1 -L 9 -i L,0,0.8 –gbar 13 -k 50000 –score-
min C,-42,0. Bowtie2 results were parsed for probes with
at least six mismatches to a non-target mRNA. Secondary
structure can have an impact on target hybridization and
probe ligation, so potential secondary structure of the fi-
nal probe sequence (hybridization arms + adapter + bar-
code) was predicted using RNAfold (25) v2.4.11 and the
dna matthews2004.par (26) model for DNA. RNAfold was
used with the following flags; -p -d2 –noLP –noPS ––noconv
–MEA. Probes were ranked by the free energy of secondary
structure, and the top 10 probes with the least secondary
structure were chosen if >10 probes were found. Probes
were ordered with a 5′ phosphate required for SplintR liga-
tion.
Barcode design with Hamming distances and error correction
8-base barcodes with a Hamming distance of 3 were de-
signed using the create.dnabarcodes (8, dist = 3) function
in DNABarcodes R package (27). For error correction, all
non-perfect matching barcodes were calculated for their
Hamming distance to all 173 reference barcodes. Any bar-
code with a minimum distance >2 to reference barcodes
were discarded. Any barcode with a non-unique minimum
distance to reference barcodes were also discarded. All non-
perfect matching barcodes with a unique minimum distance
of one or two to one of the reference barcodes were assigned
the identity of that reference barcode.
Nonamer in situ sequencing-by-ligation
Nonamer sequencing was performed following published
protocol (21) with modifications. To minimize ampli-
con movement during eight rounds of in situ sequencing
(Supplementary Figure S8), amplicons were fixed using
BS(PEG)9 (Thermo Fisher Scientific, 21582) by crosslink-
ing incorporated aminoallyl-dUTP (Thermo Fisher Scien-
tific, R1101) with surrounding proteins. After RCA, the
sample was gently rinsed once with 10 mM MES, pH 6.5.
Amplicon fixation buffer (for 200 l, use 172 l water, 4 l
500 mM MES, pH 6.5, 4 l BS(PEG)9, spike in 20 l 1 M
Borate halfway at 15 min) was added to the sample for 30
min at room temperature. Fixation reaction was quenched
by 1 M Tris–HCl, pH 8.0 and sample was rinsed three times
with 1× PBS.
For nonamer sequencing, all steps were performed on a
microscope stage where the sample was fixed in place. All
steps were performed at room temperature unless specified
otherwise. Sample was incubated with sequencing anchor
mix (1:100 dilution, anchor stock 100 M, in hybridization
buffer (6× SSC + 10% formamide)) for 15 min, followed by
three 1-min washes with 6× SSC and one rinse with 1× T4
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10 l T4 DNA Ligase, 2 l 100 M nonamer stock, 20 l
10× T4 Ligase buffer) was added to the sample for 45–60
min, followed by three 1-min washes with 6× SSC. Sample
was imaged for this sequencing position. Nonamers were
stripped away by incubating with stripping buffer (for 1000
l, use 800 l formamide, 10 l 0.01% Triton-X-100, 190 l
water) preheated to 80◦C three times for 3 min each. Three
rinses with 6× SSC was performed to remove residual for-
mamide and the sample was ready for the next sequencing
round.
Image acquisition for in situ sequencing
In situ sequencing was performed on a Nikon Ti-E In-
verted Microscope with PFS3 Yokogawa CSU-X1 spin-
ning disc confocal (Nikon). Sample was fixed on the micro-
scope stage during the eight rounds of nonamer sequenc-
ing. Sample was imaged with a 40× NA 1.1 CFI Lambda
S Apo LWD 4 Water Immersion Objective Lens (Nikon,
MRD77410). Each field of view (FOV) was 1600 × 2048
px with a 20% overlap between tiles in a 5 × 5 tile scan. 63
z-stacks with a 500-nm step size were taken for each FOV.
LUNV NIDAQ lasers (488, 561, 594, 640 nm) with 8900 Se-
dat Quad dichroic mirrors (425–477, 503–542, 571–628 and
661–728 nm) were used to distinguish the four fluorophores
(FAM, Cy3, Texas-Red, Cy5) in the nonamer mix.
In situ sequencing data pre-processing
In situ sequencing data analysis were performed as de-
scribed in Alon et al. (28). Briefly, the pipeline included
four major steps: feature-based 3D registration, back-
ground subtraction, amplicon segmentation, and basecall-
ing. Feature-based 3D registration was conducted in three
steps: keypoint detection, feature construction at a key-
point, and feature matching. The matched features were
then used to create corresponding points between differ-
ent images, which were then used to calculate a warp of
the processed image into the coordinate space of the ref-
erence image. Registered imaged were then manually in-
spected in FIJI and the non-uniform background signal
were subtracted by applying a morphological opening op-
eration of 5-pixel size, which was subtracted from the orig-
inal image. Any negative values were converted to zero. To
identify amplicons produced by RCA, a watershed trans-
form method was used. To increase the signal, grayscale
3D images after registration and background subtraction
from all in situ sequencing rounds were summed to cre-
ate a composite image. This composite image was interpo-
lated via a shape-preserving piecewise cubic interpolation
in Z and punctate signal was amplified using a Difference
of Gaussians filter. The filtered image was binarized us-
ing the Otsu method and segmented using the watershed
transform. The segmented image was uninterpolated in Z
back into the original image dimension. For basecalling,
the pixels for the four-color channels in each sequencing
round were quantile normalized to account for different flu-
orophore characteristics. For each amplicon, the normal-
ize intensities for each channel were sorted and the aver-
ages of top 30 pixels were compared. The highest channel
was selected as the color identity of this amplicon in this
in situ sequencing round. After all eight sequencing rounds
were basecalled, an eight-base barcode was concatenated
for each amplicon and mapped to the reference barcode
list.
Cell segmentation
Cell segmentation was performed on z-projected, stitched
DAPI (nucleus) + FISH (all amplicon) images according to
previous description (29). Briefly, the raw confocal image
was first processed with a gray morphology top-hat filter to
reduce background noise. To assign individual amplicons to
individual cell nuclei, DAPI channel was segmented by first
extracting the tensor structure energy, then by binary seg-
mentation and water-shedding. The perinuclear zones were
then obtained by sequential dilatations on the binary seg-
mented cell nuclei. Cell nuclei were then assigned to perinu-
clear zones by a point-in-polygon algorithm. The amplicon
number, position within perinuclear zone, and position of
a given cell nuclei were used as input for an affinity prop-
agation clustering algorithm (30), with a negative-squared-
distances similarity measure. The initial number of clusters
was set to the number of segmented cell nuclei using the ap-
clusterK function in the apcluster R package (31).
Single-cell spatial analysis
Single-cell spatial analysis was performed with Giotto R
package (32). Gene and cell filters used in this study
were: expression threshold = 1, gene det in min cells = 5,
min det genes per cell = 15. For clustering, shared nearest
neighbour (sNN) network was created with 5 dimensions
and 15 neighbors. A Leiden community detection algorithm
was used on the sNN-network with 0.1 or 0.2 resolution
and 100 iterations. Cluster markers were identified by us-
ing MAST method on the scaled expression matrix with a
P-value threshold of 0.01 and log FC threshold of 0.5. For
Delaunay spatial network creation, distance cutoff for the
nearest neighbors was 400 and minimum nearest neighbor
was 2.
RESULTS
Optimization of BOLORAMIS probe design
The workflow of BOLORAMIS consists of the following
steps (Figure 1A): (i) gene selection and probe design; (ii)
library preparation; (iii) FISH or in situ sequencing; (iv) im-
age acquisition and quantification. First, genes are selected
and probes to these genes are designed using our software.
Next, library preparation is performed on a cell line of in-
terest. During library preparation, cells are fixed and per-
meabilized, followed by hybridization of probes and RCA
primers. Hybridized probes to the target are then circular-
ized with SplintR Ligase to create RCA templates. The cir-
cular templates are amplified using the highly processive
Phi29 DNA polymerase to produce amplicons. Amplicons
are then visualized by FISH or in situ sequencing depending
on the study design. Image acquisition of the amplicons ob-
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To demonstrate that BOLORAMIS library preparation
works on diverse sample types, we targeted abundant house-
keeping genes like ACTB in cell lines (HeLa, MCF7,
HEK293, NIH-3T3) (Figure 1B) and GAPDH in sections of
human cerebral organoids (18,19) (Figure 1C). After library
preparation and FISH (Materials and Methods), dense am-
plicons generated from RCA of the targeted probes bound
to these abundant genes were observed in all sample types,
demonstrating the broad applicability of BOLORAMIS.
Previous studies on SplintR-mediated ligation showed that
ligation efficiency and specificity could be affected by the
length of 5′ and 3′ hybridization arms (15,22). The hy-
bridization length used in this study was 25 nt; together
with 23 nt of RCA primer and 12 nt of barcode, the total
length of our probe is 60 nt. This design is long enough for
sequence-specific detection (data below) and short enough
for cost-friendly synthesis where generally there is a large
increase in cost from ≤60 nt to >60 nt. To our knowledge,
our probe length is the shortest compared with previously
published work on SplintR-based in situ detection, which
are around 90 nt (33–35).
To determine the best position for placing the ligation
junction within the 25 nt region, we designed probes tar-
geting ACTB with 5′ hybridization arms ranging from 2 nt
to 22 nt, together with their negative control probes with
a single mismatch at the ligation junction targeting the ex-
act same region of the ACTB gene (Supplementary Table
S1). We quantified the number of amplicons per cell to as-
sess the relative efficiency of these positions and calculated
true discovery rate (TDR, Materials and Methods and Sup-
plementary Table S4) to assess their accuracy. The probe
that produced maximal amplicon and also had a high TDR
value was the one which had 18 nt on the 5′ arms and 7 nt
on the 3′ arms (Figure 1D–F; Supplementary Figure S1).
This probe configuration was used for downstream studies.
It is worth noting that even when targeting a gene as abun-
dant as ACTB, a single mismatch at the ligation is enough
to abolish over 95% of the signal in the 18 + 7 nt group. This
indicates that if the ligation junction is placed exactly upon
a point mutation within a transcript, BOLORAMIS probes
have the potential to detect the single point mutation.
Singleplex detection of coding and non-coding RNAs using
individual probes
To determine if BOLORAMIS can work on a wide range of
RNA targets in addition to abundant genes such as ACTB
and GAPDH, we evaluated BOLORAMIS’ performance in
detecting coding and non-coding RNA targets, individu-
ally, in a biologically meaningful context. We designed 77
probes targeting 77 miRNAs and 192 probes targeting 77
mRNA of transcription factors (TFs), expressed at varying
abundance levels in human iPSCs (Supplementary Meth-
ods, Supplementary Table S2) (16). Multiple probes target-
ing different regions of the same TF transcripts were de-
signed to evaluate the variability in detection. Because the
mature miRNAs we chose to target have a length between
18–23 nt, which is shorter than 25 nt, the following param-
eters were applied during probe design: (i) that the entire
length of the miRNA (18–23 nt) is used for targeting; (ii)
that the 3′ arm is at least 7 nt and (iii) that poor ligation
junctions are avoided, as listed in Supplementary Figure S7.
Each probe was tested individually in situ in PGP1 human
iPSCs in 384-well plates. Single-cell spot counts were quan-
tified from a total of 217 206 human iPSCs using automated
imaging and an image-processing pipeline (Supplementary
Figure S2, Supplementary Methods).
On the whole, BOLORAMIS expression values in hu-
man iPSCs were indicative of a stem cell expression signa-
ture (Supplementary Figure S3). Of note, some of the high-
est ranked mRNAs corresponded to pluripotency mark-
ers (ZFP42, GATA2, SMAD1, ID1, KAT7, OCT4, SOX2,
NANOG and ZFX) (Supplementary Figure S3A). Con-
versely, mRNAs with the lowest BOLORAMIS single-cell
expression values were associated with promoting cellular
differentiation. For example, the lowest ranked TFs were
NR61A, NEUROG1, LIN28B, TAL1, NR4A2, CREB1,
OLIG2 and NEUROG2 (Supplementary Figure S3A). Ex-
ample microscopy images used for quantification are shown
in Supplementary Figure S4. Single cell BOLORAMIS
expression counts varied between 1–1000 spots/cell with
a mean of 53.8 ± 74.9 SD. The highest detected mean
BOLORAMIS expression value was 236.95 amplicon/cell
(ZFP42, a pluripotency gene, Supplementary Figure S3B),
which is comparable with the reported upper-limit of high-
throughput branched DNA (bDNA) smFISH detection at
similar magnification (36,37).
We next compared BOLORAMIS mRNA measurements
with published RNA-seq values. Overall, BOLORAMIS
probes exhibited a low-positive correlation with bulk RNA-
seq values (Pearson’s r: 0.142). We suspect that the low cor-
relation might likely be resulting from the variable efficiency
between single probes to detect their targets. To test this hy-
pothesis, we calculated the coefficient of variation (COV)
of amplicon number generated by probes targeting different
regions of the same transcript. The mean COV between at
least two independent probes targeting the same RNA was
52.63 ± 29.46% (SD, n = 53, Supplementary Figure S3D).
One factor previously reported to affect SplintR Ligase ac-
tivity was the bases near the ligation junction (22). To in-
vestigate if differences in ligation junction could contribute
to the variability of detection, we looked at correlation with
bulk RNA-seq values while grouping probes by their liga-
tion junction sequences (Supplementary Figure S3H, Sup-
plementary Table S15). We observed a wide range of Pear-
son correlation values ranging from -0.3 to 0.9. The three
lowest correlation junctions (5′/3′) were TG (n = 16), CG
(n = 9) and GA (n = 19), which is consistent with previous
reports about poor ligation activity on junctions containing
G. The three highest correlation junctions were TC (n = 10),
CC (n = 4) and AC (n = 13). While it may seem reasonable
to prioritize these junctions in future experiments, we would
like to point out that the limited size of the sample and
other factors could also affect probe efficiency, including se-
quences surrounding the actual junction bases (22), melting
temperature of the 25 nt targeting region (Supplementary
Table S14), local secondary structures of the transcripts,
and bound proteins that could block hybridization. With
these in mind, we suggest that even though BOLORAMIS
can work with a single probe, to accurately determine the
relative expression level of mRNAs, it would be beneficial
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script. We used this format of using multiple probes per
transcript detection for downstream experiments.
Due to RNA size constrains and variations, miRNA
can only be targeted with one probe and we prioritized
ligation junction compatibility with SplintR (22) over the
18/7 hybridization arm design. We selected 77 miRNAs
with published bulk NanoString nCounter expression mea-
surements in PGP1 human iPSC (16) (Supplementary Fig-
ure S3C). BOLORAMIS count of 77 miRNAs exhibited a
poor correlation with published bulk measurements (Pear-
son’s r: 0.067). However, for a given probe, we observed
mostly reproducible mean spot counts per cell for indepen-
dent BOLORAMIS assays (Pearson’s r: 0.62, Supplemen-
tary Figure S3F, G). This suggested that although the exper-
iment is reproducible, the relative miRNA expression level
determined by BOLORAMIS is not consistent with bulk
measurements (Discussion).
Determining specificity and sensitivity of BOLORAMIS
To show that transcripts with high sequence similarity
can be distinguished by BOLORAMIS before performing
multiplexed in situ sequencing experiments, we designed
probes that specifically targeted human or mouse genes
(ACTB and GAPDH). Each transcript was targeted with
a pool of three probes at different and specific regions on
ACTB and GAPDH mRNA (Supplementary Tables S1
and S5). For each gene, three probes each targeting human
and mouse transcripts were pooled together and used for
BOLORAMIS library preparation in a co-culture of human
MCF7 and mouse NIH-3T3 cell lines. We observed clear
separation of human and mouse targets based on the FISH-
stained images (Figure 2A–D). In putative mouse cells, 94.6
± 1.8% (n = 5) ACTB amplicons, and 98.4 ± 1.3% (n =
8) GAPDH amplicons were detected for mouse Actb and
Gapdh respectively; while in putative human cells, 93.1 ±
5.2% (n = 10) ACTB amplicons and 83.4 ± 6.6% (n = 7)
GAPDH amplicons were observed for human ACTB and
GAPDH respectively (Supplementary Table S6). These re-
sults indicated probe specificity between transcripts that are
highly similar in their gene sequences. BOLORAMIS was
also able to specifically detect subcellular localization of
transcripts. We observed long non-coding RNA (lncRNA)
MALAT1 exhibiting two distinct subcellular localization
patterns in HeLa cell cultures, where in each cell MALAT1
was found in either the nucleus or in the cytoplasm (Fig-
ure 2E). This observation was confirmed by smFISH (Fig-
ure 2E) and has also been demonstrated by previous studies
(38,39).
To determine the sensitivity of BOLORAMIS, we com-
pared our method with smFISH, which is considered as
the ‘gold standard’ for in situ molecule counting. We tar-
geted three genes with validated commercially available sm-
FISH probes (Stellaris): GAPDH, POLR2A and TFRC.
These three genes were chosen such that they had vari-
able expression levels and the probes were readily available
for shipping. Each transcript was targeted with a probe
pool at ten different and specific regions on the mRNA
and BOLORAMIS was performed in HeLa cells (Supple-
mentary Table S1, Figure 2F). The number of spots per
cell was counted for the two methods, and sensitivity was
calculated by dividing the average number of spots per
cell from BOLORAMIS by that from smFISH. The de-
tection sensitivity of BOLORAMIS compared to smFISH
for the three genes was 11% (GAPDH), 35% (POLR2A)
and 12% (TFRC), respectively (Figure 2G, Supplemen-
tary Table S7). The differences observed between sensitiv-
ity of smFISH and BOLORAMIS could be a result of
additional enzymatic steps used in BOLORAMIS proto-
col, including SplintR ligase-mediated probe circulariza-
tion and Phi29 polymerase-mediated RCA. However, the
sensitivity of our method is still comparable to the widely
used high throughput single-cell RNA sequencing tech-
nologies, which is around 10–30% (40,41). Additionally,
BOLORAMIS has potential for highly multiplexed detec-
tion, whereas conventional smFISH is limited to 3–5 tar-
gets.
Before performing a multiplexed experiment using
BOLORAMIS, we wanted to investigate how the accu-
racy of detection changed with increased number of probes
per gene. To test this, we picked eight genes with differ-
ent expression levels based on bulk RNA sequencing data
from MCF7 cells and PGP1 human fibroblasts: CSDE1,
SPTSSB, DDX5, SLC39A6, EEF1A2, CALR, FLNA and
TFRC. Using our automated probe design software (Mate-
rials and Methods, Supplementary Figure S7), we designed
and synthesized 2, 5, 10 and 24 probes for each gene. The
four probe pools for the eight genes were tested in dupli-
cates in each cell type (Supplementary Figure S5, S6A, B).
After image quantification, we observed a clear trend of in-
crease in puncta per cell for all eight genes as the number
of probes increased (Supplementary Figure S5A, C, S6A,
B). Of note, in all samples the total probe concentrations
were kept the same at 1 M, indicating a more diverse probe
pool is likely to yield a better detection for the gene. To
test if the relative expression levels between genes are better
captured by BOLORAMIS when more probes are used per
gene, we correlated the mean puncta number per cell for the
eight genes with their corresponding transcripts per million
(TPM) values from bulk RNA sequencing. In both MCF7
cells and PGP1-fibroblasts, we observed an increased Pear-
son correlation coefficient with bulk RNA-seq when probes
per gene increased from 2 to 5. However, we did not ob-
serve a further increase in correlation when 10 or 24 probes
were used (Supplementary Figure S5B, D). The correlation
coefficient hovered around 0.5 even when 24 probes were
used per gene, indicating the limitation of BOLORAMIS
for accurate quantification of gene expression. Even though
BOLORAMIS detection is feasible with a single probe, as
demonstrated earlier on ACTB, we recommend using 5–
10 probes per gene as a test starting point when designing
probes for new experiments.
To assess the reproducibility to BOLORAMIS detection,
we looked at puncta number per cell from the duplicated
samples from the above experiments for eight genes (Sup-
plementary Figure S6A, B), as well as a triplicated measure-
ment for two genes in two cell lines (Supplementary Figure
S6C, D). In both experiments, we observed overall high con-
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Figure 2. Specificity and sensitivity of BOLORAMIS. (A–D) Specific detection of ACTB (n = 15) and GAPDH (n = 15) in the co-culture of MCF7 (human,
scale bar: 50 m) and NIH-3T3 (mouse, scale bar: 50 m) cells. (E) Subcellular localization of lncRNA MALAT1 detected by smFISH and BOLORAMIS
(scale bar: 10 m). Left, cytoplasmic; right, nuclear. (F) Images for side-by-side comparison of smFISH and BOLORAMIS for detecting the same genes
in HeLa cells (scale bar: 50 m). (G) Quantitative comparison with smFISH in HeLa cells for detection of GAPDH (n = number of cells, smFISH n = 6,
BOLORAMIS n = 9), POLR2A (smFISH n = 7, BOLORAMIS n = 17) and TFRC (smFISH n = 11, BOLORAMIS n = 22).
Demonstrating multiplexing of BOLORAMIS and deter-
mining spatial gene expression patterns
Having optimized the probe configuration, benchmarked
the specificity and sensitivity, we set out to study single-
cell and spatial heterogeneity of cells in a neuron/microglia
co-culture. Microglia play important roles in brain devel-
opment and disease (42). Microglia have been implicated
to play major roles in neurodegenerative diseases, such as
Alzheimer’s disease, through their tight link between in-
flammation and neuron survival (43,44). We wanted to de-
termine if the interplay between neuron and microglia could
be partially replicated in an in vitro co-culture experiment.
To demonstrate the ability of BOLORAMIS to study
single-cell and spatial patterns of the transcriptome, we tar-
geted 96 mRNAs simultaneously in a co-culture of iNGN
neurons (16) and a human microglial cell line (HMC3)
(17). Based on differential gene expression analysis of bulk
RNA sequencing data from the monoculture of iNGN and
HMC3, the 96 genes were selected to include 40 iNGN-
enriched genes, 16 common genes and 40 HMC3-enriched






/nar/advance-article/doi/10.1093/nar/gkab120/6163087 by guest on 23 April 2021
10 Nucleic Acids Research, 2021
Figure 3. Multiplexed detection of 96 genes in a co-culture of HMC3 and iNGN. (A) Selection of 96 genes from differential gene expression analysis
(blue, iNGN enriched; green: HMC3 enriched; Orange: shared). (B) Statistics for error correction of barcodes. (C) Clustering analysis of segmented single
cells (Leiden resolution = 0.1). (D) Spatial visualization of segmented cells with their predicted cell type. Dashed box zoomed in panel E. (E) Side-by-
side comparison of classified single cells and segmented nucleus + amplicon images. (F) Cluster markers identified by MAST, side-by-side with log2fc
values from bulk RNA-seq data, indicating consistency between BOLORAMIS and RNA-seq for cell marker identification. (G, H) UMAP and spatial
visualization of NEUROG1 (iNGN-enriched), and GREM1 (HMC3-enriched).
span a range of >600-fold difference in their expression
levels, with DESeq2 (20) baseMean value ranging from
the lowest 64 (TLR4) to the highest 39652 (NEFM), with
ACTB’s value being 76 117 as a reference (Materials and
Methods). Similar to the smFISH comparison experiment,
most of the transcripts were targeted with 9–10 probes
with the common 8-nt barcode. In addition to the 96 mR-
NAs, we also targeted 77 miRNAs with known expres-
sion data in iNGN (16) to assess the ability of our current
BOLORAMIS protocol on miRNA detection. Thus, a to-
tal of 957 mRNA probes + 77 miRNA probes (Supplemen-
tary Table S3) with 96 unique mRNA barcodes (one bar-
code per gene) + 77 miRNA barcodes were pooled in this
multiplexing experiment. The specificity, ligation junction
and secondary structure of the probes were checked using
our custom probe design software (Materials and Methods,
Supplementary Figure S7). We used this probe set to per-
form BOLORAMIS on the co-culture of iNGN and HMC3
cells. After library preparation, the sample was sequenced in
situ for 8 cycles using nonamer sequencing-by-ligation (21)
(Supplementary Figure S8).
After image registration, spot identification, base-calling
and barcode identification (Materials and Methods), 94
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1200 m. 70.5% (66 410) of the amplicons had a perfect
match to the reference barcode list (Supplementary Table
S9 and S10). The barcodes were designed to be robust to se-
quencing errors by enforcing a Hamming distance of 3 (27).
We therefore identified single and double nucleotide errors
and recovered 18 715 additional amplicon barcode iden-
tities (Materials and Methods, Figure 3B). Among iden-
tified amplicons, we observed non-zero counts for all 96
mRNA targets (Supplementary Figure S9), with the high-
est count for NEFM (12701 amplicons) and lowest count
for KLF2 (2 amplicons). Of note, among the 66 410 perfect
matching barcodes, only 10 (<0.02%) were miRNA bar-
codes, with a count of 1 for 10 different miRNAs. How-
ever, among the 18,715 barcodes recovered from error cor-
rection, 1244 (6.6%) were miRNA barcodes. The reason for
overrepresented erroneous barcodes for potential miRNA
reads (Supplementary Figure S9) remains to be determined.
Due to the anomalous results of miRNA detection, includ-
ing low counts and high barcode error rate, reads from
the 77 miRNAs were excluded from downstream analy-
sis. This data also suggested that the current iteration of
BOLORAMIS protocol needs to be further optimized for
miRNA detection (Discussion).
Single cells were segmented on the DAPI (nucleus) +
FISH (all amplicons) image using an affinity propagation
clustering algorithm (29,31). Accurate segmentation of sin-
gle cells was confirmed by visual assessment (Figure 3E,
Supplementary Figure S11). A cell-by-gene raw count ma-
trix (Supplementary Table S11) and a list of cell centroids
(XY coordinates, Supplementary Table S12) were used as
input for single-cell spatial analysis using Giotto (32). Af-
ter applying gene and cell filters (Materials and Methods),
92 mRNAs and 423 cells were used for further analysis. On
average, 263 reads were acquired from each single cell, de-
tecting 36 different mRNA targets (Supplementary Figure
S10A, B). Single-cell clustering analysis identified two cell
clusters (Figure 3C), which were annotated as HMC3 (340
cells) and iNGN (83 cells) according to the cluster mark-
ers identified (Figure 3F and Supplementary Figure S12D).
Spatial distribution of annotated single cells is shown in
Figure 3D. Markers identified for putative HMC3 cells
(including COL1A1, SERPINE1, AXL, FLNA, MYL9,
GREM1) were highly consistent with bulk RNA-seq data
as indicated by a side-by-side comparison with log2fc val-
ues from DESeq2 (Figure 3F), the same was true for puta-
tive iNGN cells (including NCAM1, NEUROG1, STMN2,
NHLH1, NEFL) (Supplementary Table S8). Cluster and
spatial distribution of genes including NEUROG1 (iNGN-
enriched, Figure 3G), GREM1 (HMC3-enriched, Figure
3H) and additional ones (Supplementary Figure S13, Sup-
plementary Table S8) agreed with expectations based on
bulk RNA-seq data. The relative expression levels of all 96
mRNA targets observed by BOLORAMIS were compared
with RNA-seq expression data, showing a Pearson corre-
lation coefficient of 0.55 before barcode error correction
and 0.62 after error correction (Supplementary Figure S10).
This indicates that even though BOLORAMIS is good at
capturing spatial patterns of genes, the accuracy for mea-
suring relative gene expression levels can still be improved.
To reveal spatial relationships between genes, we per-
formed a gene-gene proximity analysis (Supplementary
Methods, Supplementary Figure S14A–C). By perform-
ing an unbiased hierarchical clustering with the gene–gene
proximity value matrix, two groups of genes immediately
stood out to our attention: one containing NHLH1, NEU-
ROG1, STMN2 and SOX11, and the other containing
COL1A1, SERPINE1, FLNA and VIM (Supplementary
Figure S14D). Based on previous bulk RNA-seq and single-
cell clustering results in Figure 3, 14 out of 14 mRNAs from
the first group were iNGN-enriched genes, and 23 out of
35 mRNAs from the second group were HMC3-enriched
genes, indicating that genes enriched in the same cell type
occurred more frequently together as compared to genes
that were enriched in a different cell type.
Single-cell and spatial heterogeneity analysis of
neuron/microglia co-culture
As shown in the analysis above, with a clustering resolution
of 0.1, we were able to identify the two cell types (iNGN
and HMC3) seeded in the co-culture experiment. To reveal
heterogeneity within one cell type or to identify cell sub-
types, a higher clustering resolution could be used. In or-
der to determine if BOLORAMIS could capture hetero-
geneity within one cell type, we increased the resolution
of cell clustering (from 0.1 to 0.2, Materials and Meth-
ods) and identified two sub-clusters within the HMC3 clus-
ter, suggesting heterogeneity within this population (Fig-
ure 4A, B). We called the two sub-populations of the mi-
croglia ‘HMC3 1’ and ‘HMC3 2’. By comparing mRNA
expressions between clusters, we identified genes that were
differentially expressed between HMC3 1 and HMC3 2
(Figure 4C). Compared with HMC3 2, HMC3 1 is en-
riched for genes including PNMA3, RXRG and TRIM55,
while depleted of genes including ZBED2, TERF2, and
HOXB4. We were curious to see if spatial relationships be-
tween cells within the co-culture could be a relevant fac-
tor for this heterogeneity. To quantify the spatial relation-
ships between cells, we built a spatial network based on
cell centroid distances using the Delaunay method (32)
(Figure 4D). Within this network, each node is a cell,
and each edge is a cell–cell interaction. By counting the
numbers of observed interactions and comparing against
the simulated numbers from computationally-reshuffled
network, we observed that homo-interactions (iNGN–
iNGN, HMC3 2–HMC3 2, HMC3 1–HMC3 1) occurred
more frequently than hetero-interactions (HMC3 1–iNGN,
HMC3 2–iNGN) (Figure 4E). We also found that HMC3 1
interacted with iNGN relatively more frequently than with
HMC3 2 (Figure 4E). This is especially interesting because
we also observed 16 genes that had similar enrichment pro-
file between iNGN and HMC3 1, but depleted in HMC3 2,
including OLIG3, NEUROD1 and TLR4. We ruled out the
possibility of erroneous segmentation due to close proxim-
ity because many other highly expressed iNGN-enriched
genes, including NHLH1, NEUROG2, NCAM1, were not
observed in HMC3 1. The shared gene expressions between
iNGN and HMC3 1 could be related to their more frequent
spatial interactions. This type of analysis would be espe-
cially useful in a complex tissue setting, where cellular or-
ganization could be altered as a result of development, dis-
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Figure 4. Single-cell and spatial heterogeneity in neuron/microglia co-culture revealed by BOLORAMIS. (A) Higher resolution of Leiden community
detection (resolution = 0.2) revealed sub-clusters with HMC3 cells. (B) Cell number of each cluster. (C) Z-score heatmap of post-QC mRNAs expression
in three clusters. (D) Spatial network based on cell centroid distances using Delaunay method. (E) Observed over expected frequency of cell-cell proximity
interactions with 2000 simulations. Each simulation reshuffles the cell type labels of each node in the spatial network.
above, we concluded that BOLORAMIS was able to reveal
single-cell and spatial patterns of the transcriptome.
DISCUSSION
Spatial transcriptomics is a rapidly evolving field and the
interests of obtaining 3D information of transcripts in
cells, tissues, and even whole organisms have sparked the
development of a number of promising technologies, in-
cluding but not limited to in situ padlock (6), FISSEQ
(5,45), ExSeq (28), MERFISH (10), seqFISH+ (12,13),
slide-seq (46), HDST (47), INSTA-seq (48) and STARmap
(14). In this repertoire, we have added another technol-
ogy, BOLORAMIS, to the arsenal of spatial transcrip-
tomics (Supplementary Table S16). Compared with untar-
geted methods, including FISSEQ, untargeted ExSeq, slide-
seq, HDST and INSTA-seq, BOLORAMIS offers higher
sensitivity by targeting specific genes of interest in a highly
multiplexed manner. Compared with in situ padlock probe
methods, BOLORAMIS removes the need for RT by us-
ing a RNA-splinted DNA ligase, thus reducing potential
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Compared with other RT-free methods, including MER-
FISH, seqFISH+ and STARmap, BOLORAMIS demon-
strates the shortest foot-print needed for detecting tran-
scripts in situ, which is 25 nt. Although MERFISH and se-
qFISH+ have demonstrated superior sensitivity, amplicon-
based methods like BOLORAMIS, STARmap, in situ pad-
lock and ExSeq are more readily applicable in thick tissue
samples because of stronger signals resulting from RCA.
In the current study, we have demonstrated the feasibility
of using the BOLORAMIS protocol on multiple cell lines
and human cerebral organoids. This provides a new way of
probing 3D transcriptomic architecture of organoids and
opens up new opportunities for studying brain disorders,
such Alzheimer’s disease (49), schizophrenia and bipolar
disorders (unpublished data). We have also optimized the
configuration of BOLORAMIS probes to allow for a high
TDR while not sacrificing detection efficiency. We show that
BOLORAMIS is very specific to genes with highly sim-
ilar sequences, which opens up opportunities for detect-
ing gene isoforms and mutations. We found the sensitiv-
ity of BOLORAMIS to range between 11 and 35% when
comparing spots per cell of the same gene with smFISH,
which is comparable to the sensitivity of high-throughput
single-cell RNA sequencing (40,41). Finally, we success-
fully demonstrated multiplexed in situ RNA detection us-
ing BOLORAMIS by targeting 96 mRNAs and revealed
the spatial clustering patterns of cells in a neuron/microglia
co-culture system. Hence, we believe our technology will be
useful for studying spatial gene expression in more complex
settings, including primary tissues and organoids.
Compared with previous reports on SplintR-based in situ
detection methods (33–35), we have made significant im-
provements on probe design and sequencing chemistry to
really allow for highly multiplexed in situ investigations.
First, our probe length is only 60 nt while previously re-
ported probes are around 90–100 nt (33–35), thereby signifi-
cantly reducing the cost for probe synthesis (Supplementary
Figure S15A), which makes our method more amenable to
highly multiplexed experiments. We also performed a cost
analysis for different strategies of probe library synthesis,
including regular tube order, plate order (this study), oligo
pools and array-based DNA synthesis. Based on the analy-
sis, array-based DNA synthesis can be used to bring down
the cost for genome-wide probe synthesis (Supplementary
Figure S15B, Supplementary Table S13). We reported an
approach to generate padlock probe library from array-
synthesized DNA pools in a previous study (50). The probe
cost can be further reduced by performing phosphorylation
in-house using T4 polynucleotide kinase. Second, we have
provided a ready-to-use automated probe design software
that checks for targeting arms specificity, ligation junction
compatibility with SplintR (22) and probe secondary struc-
ture. With a list of targeted transcript sequences and a refer-
ence genome, a library of probes can be designed easily and
ready for synthesis. Lastly, adopting nonamer sequencing-
by-ligation allowed us to encode a large diversity of targeted
transcripts into barcode sequences as short as 8 nt. The up-
per limit of this encoding scheme is 48 = 65 536 targets,
well above the number of genes in the human genome. Spa-
tial crowdedness could be a challenge when targeting many
genes, which is common to all RCA-based approaches.
With each amplicon being around 400–800 nm in diam-
eter (45), the number of reads that can be obtained from
each cell is likely limited to a couple of hundreds to lower
thousands. This limitation can be overcome by combining
BOLORAMIS with Expansion Microscopy (51,52), which
has been successfully demonstrated by our colleagues in a
recent publication (28). When compared with bulk RNA-
seq data, quantifying relative gene expression levels is a limi-
tation of BOLORAMIS. This limitation could also be over-
come by performing BOLORAMIS in a hydrogel-expanded
sample with Expansion Microscopy (28). The process of ex-
panding tissue in the hydrogel removes proteins/lipids thus
potentially increasing the availability of transcripts for hy-
bridization. The physical expansion of each cell also results
in spatial decrowding, giving more room for amplicons, thus
producing a higher read number per cell.
SplintR Ligase has been demonstrated for detection of
miRNA from extracted total RNA (15), indicating a possi-
bility for multiplexed in situ detection using BOLORAMIS.
Although we observed reproducible signals for miRNAs
from the high-throughput singplex experiment, our attempt
to detect miRNA in the multiplexed in situ sequencing ex-
periment was not successful. Factors that could explain this
include: (i) lower effective concentration for each probe in
the multiplexed experiment (10 nM in the multiplexed ex-
periment due to pooling of 1034 probes versus 1 M for
each probe in singplex experiment); (ii) shorter probe hy-
bridization time in the multiplexed experiment (1 h versus
16 h); (iii) larger washing volume for multiplexed experi-
ment (96-well plate equivalent versus 384-well plate). Op-
timization of RNA fixation protocol can also be helpful
for miRNA detection (53). Further exploration of probe
concentration, fixation method, hybridization and washing
conditions might yield better miRNA detection, which is
beyond the scope of this study. Although our results indi-
cated that further optimization is needed for detection of
miRNA, BOLORAMIS could bring new opportunities for
highly multiplexed in situ detection of alternative splicing
events and short transcripts, which will be useful for study-
ing disease pathology and diagnosis (54). BOLORAMIS
can also be applied to optical pooled screens (55) for detec-
tion of guide RNAs and short barcodes for perturbations.
With its unique RT-free and short arm targeting strategy,
BOLORAMIS can be used as a practical tool for devel-
opmental biology research, functional genomic studies, dis-
ease prognosis and novel therapeutic developments.
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